Gene Delivery Technologies Market Size, Share, Trends, Industry Analysis & Growth 2032

Gene Delivery Technologies Market Insights

According to the report published by Zion Market Research, the global Gene Delivery Technologies Market size was valued at USD 5.61 Billion in 2023 and is predicted to reach USD 13.40 Billion by the end of 2032. The market is expected to grow with a CAGR of 9.1% during the forecast period. The report analyzes the global Gene Delivery Technologies Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Gene Delivery Technologies industry.

Request Free Sample

Global Gene Delivery Technologies Market: Overview

The method of introducing foreign gene such as RNA or DNA into the host cells is called gene delivery. The process of gene delivery uses viral, chemical, or physical means for the introduction of the genetic material into the cells thus enhancing or amplifying their functions and harnessing their therapeutic potential. It utilizes non-immunogenic vectors that have the ability of cell specificity and can deliver an appropriate amount of transgene expression. Gene delivery technology is been used in gene therapy to deliver genetic material for the treatment of the disease.

Global Gene Delivery Technologies Market: Growth Factors

The global gene delivery technologies market is growing at a lucrative rate. Factors contributing to the growth of the global market include increasing research on advanced cell and gene therapies for the treatment of chronic diseases, growing investments in research & development activities by the public & private sector, and a growing focus on advanced gene delivery therapies by major players is primarily driving the growth of the global gene delivery technologies market. There is a wide range of gene delivery technologies such as viral transfection, cationic lipid transfection, electroporation, calcium phosphate transfection, and DEAE-dextran transfection which are used in the field of molecular biology for the development of new drugs.

Further, developments in genomics have enabled several new methods and gene targets to be known for numerous applications. These and many other factors are contributing to the growth of the market. On the other hand, expensive methodology and high investment in research & product development may hamper the growth of the market over the forecast period. However, greater efficiency of gene delivery technologies to produce effective recombinant drugs will provide better growth opportunities to the market during the forecast period.

The rapid spread of Covid-19 has a multifaceted impact on the global gene delivery technologies market. The cell and gene therapy companies are particularly hit hard by the Covid-19 pandemic due to their complex manufacturing, delivery, and funding model. The Covid-19 crisis has disrupted the commercial operations, research & clinical development, and manufacture & delivery of treatments. The supply problems have also led to several problems. On the other hand, the government of several countries is providing funds and support to the large pharmaceuticals and biotechnology companies to develop a Covid-19 vaccine. Some of the major players signed an agreement for the manufacture of adenovirus vector-based vaccine for Covid-19. The pharmaceutical companies are bringing their development programs back on track. Thus, the global gene delivery technologies market experienced a steady growth rate during the pandemic.

Request Free Sample

Global Gene Delivery Technologies Market: Segmentation

The global gene delivery technologies market is classified based on application, mode, method, and region.

Based on the application, the global gene delivery technologies market is fragmented into cell therapy, gene therapy, research, and vaccines.

Based on the mode, the global market is segregated into chemical, biological, and physical. The method application is bifurcated into in vivo, ex vivo, and in vitro.

Gene Delivery Technologies Market: Report Scope

Global Gene Delivery Technologies Market: Regional Analysis

North America is expected to dominate the global gene delivery technologies market in terms of revenue over the forecast period. Factors that are contributing to the growth of the gene delivery technologies market in this region include the growing need for an advanced recombinant drug to treat chronic diseases, high investments in research & development by the public as well as the private sector, and presence of major biopharmaceuticals in this region. They are contributing to generate significant revenue in this region. Europe is expected to stay in the second position in the global gene delivery technologies market. However, the rapid growth of the market is expected in Asia Pacific region. Increasing investments in research & development in the field of life sciences, availability of skilled workforce in the region, and large local market for innovative drugs is expected to provide exponential growth opportunities to the market over the forecast period.

Global Gene Delivery Technologies Market: Competitive Players

The global gene delivery technologies market is highly competitive due to advancements in the technologies and adoption of gene delivery for the treatment of diseases. Some of the giant players in the global market are:

• Hoffmann-La Roche AG
• System Biosciences llc
• Takara Bio Inc
• SignaGen Laboratories
• OriGene Technologies, Inc
• QIAGEN
• Thermo Fisher Scientific, Inc
• Promega Corporation
• Oxford Biomedica
• Horizon Discovery Group Co.

The Global Gene Delivery Technologies Market is segmented as follows:

By application 

• cell therapy
• gene therapy
• research
• vaccines

By mode 

• chemical
• biological
• physical

By method 

• vivo
• ex vivo
• in vitro

Global Gene Delivery Technologies Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.